Skip to main content
. 2023 May 22;14:1131354. doi: 10.3389/fphar.2023.1131354

TABLE 2.

Side effects reported after the use of escitalopram for functional gastrointestinal disorders.

(n = 51) n (%)
Apathy, n (%) 3 (5.88%)
Xerostomia, n (%) 12 (23.53%)
Diaphoresis, n (%) 7 (13.73%)
Abnormal dreams, n (%) 2 (3.92%)
Flu like symptoms, n (%) 6 (11.76%)
Weight loss, n (%) 2 (3.92%)
Weight gain, n (%) 9 (17.65%)
Increase appetite, n (%) 2 (3.92%)
Decrease appetite, n (%) 1 (1.96%)
Headache, n (%) 5 (9.80%)
Nausea and vomiting, n (%) 11 (21.57%)
Numbness, n (%) 3 (5.88%)
Sexual disorders, n (%) 2 (3.92%)
Yawning, n (%) 10 (19.61%)
Diarrhea/Constipation, n (%) 6 (11.76%)
Palpitation, n (%) 1 (1.96%)
Abdominal bloating, n (%) 3 (5.88%)
Abdominal cramps, n (%) 1 (1.96%)
Drowsiness/Fatigue/Dizziness, n (%) 28 (54.90%)
Agitation/depression, n (%) 2 (3.92%)
Abdominal pain, n (%) 1 (1.96%)
Insomnia, n (%) 3 (5.88%)
Involuntary movement, n (%) 1 (1.96%)
Mood changes, n (%) 1 (1.96%)